Subtype
Malignant Hepatobiliary Neoplasm
CI-CAN-00001136Explore in graph →
1,160 active trials17 approved drugs42 evidence items
- NCIt
- C8609
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001136Explore in graph →
Clinical trials
5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (561)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05732181 | The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation | completed | N/A | 154 | National Cheng-Kung University HospitalOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05475054 | Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classes(MILSOBES) | completed | — | 9,963 | Fondazione Poliambulanza Istituto OspedalieroOTHER | 1 |
| Feb 15, 2023 |
| clinicaltrials |
| NCT05729230 | PAtient-PHYsician Relationship Assessment(PAPHYRA) | completed | — | 50 | Erasme University HospitalOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT04248816 | Hepatocellular Carcinoma Surveillance in Cirrhotics | completed | N/A | 615 | University of PennsylvaniaOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT05352204 | Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas | completed | — | 900 | Zhejiang UniversityOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT03248375 | Impact of Y90 Radiation Segmentectomy on HCC | completed | N/A | 29 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05720195 | ALBI and PALBI Scores and HCC Prognosis | completed | — | 645 | Sohag UniversityOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT04194801 | A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 26 | CStone PharmaceuticalsINDUSTRY | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05638048 | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients | completed | N/A | 270 | Junyan ZhaoOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT05471674 | Neoadjuvant Anti-PD1 in HCC | completed | Phase 2 | 20 | Dr Tan-to CHEUNGOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT03980288 | 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3 | completed | Phase 1 | 6 | Zhejiang UniversityOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT02438436 | Simo Decoction and Gum Chewing for Bowel Activity(SD/GC-HCC) | completed | Phase 3 | 180 | Guangxi Medical UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT02654028 | Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection(AT/HCC) | completed | N/A | 618 | Guangxi Medical UniversityOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT04476082 | Nutrition in Gastrointestinal Tumors(NutriGIT) | completed | — | 66 | University Medicine GreifswaldOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT02435433 | A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein(REACH-2) | completed | Phase 3 | 399 | Eli Lilly and CompanyINDUSTRY | 20 | Jan 20, 2023 | clinicaltrials |
| NCT04430842 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | completed | Phase 1 | 15 | Quadriga Biosciences, Inc.INDUSTRY | 1 | Jan 18, 2023 | clinicaltrials |
| NCT03867916 | Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients | completed | N/A | 106 | University of California, San FranciscoOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05681234 | Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma | completed | N/A | 30 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT03648073 | [68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 12 | University of Alabama at BirminghamOTHER | 1 | Jan 10, 2023 | clinicaltrials |
| NCT05225207 | A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants | completed | — | 658 | Eisai Korea Inc.INDUSTRY | 1 | Jan 9, 2023 | clinicaltrials |
| NCT01642186 | Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | completed | Phase 2 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT04763707 | Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis | completed | — | 87 | Sohag UniversityOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT02794805 | Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis | completed | Phase 2 | 74 | Meridian Bioscience, Inc.INDUSTRY | 1 | Dec 20, 2022 | clinicaltrials |
| NCT01116804 | Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 36 | University Hospital, GhentOTHER | 1 | Dec 15, 2022 | clinicaltrials |
| NCT01177397 | Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma | completed | Phase 1 / Phase 2 | 226 | CelgeneINDUSTRY | 4 | Dec 13, 2022 | clinicaltrials |
| NCT00286013 | Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma | completed | Phase 2 | 24 | University Hospital, GhentOTHER | 1 | Dec 9, 2022 | clinicaltrials |
| NCT05643833 | Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma | completed | — | 3,769 | Zhejiang UniversityOTHER | 1 | Dec 9, 2022 | clinicaltrials |
| NCT02013492 | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | completed | Early Phase 1 | 1 | William CarsonOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT03079427 | Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma | completed | Phase 2 | 101 | Asan Medical CenterOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT04172714 | Low-dose Y90 Treatment Planning for HCC | completed | N/A | 30 | Emory UniversityOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT04310709 | Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma(RENOBATE) | completed | Phase 2 | 42 | Asan Medical CenterOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT03233360 | Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry(INSIGHT) | completed | — | 2,533 | National Cancer Centre, SingaporeOTHER | 9 | Dec 5, 2022 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT02810652 | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | completed | N/A | 160 | Massachusetts General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT00956930 | Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery | completed | Phase 2 | 45 | Northwestern UniversityOTHER | 1 | Nov 21, 2022 | clinicaltrials |
| NCT03379844 | HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients | completed | Phase 2 | 30 | UMC UtrechtOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT01180959 | Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy | completed | Phase 2 | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05606029 | A Case Series on Incidentally Detected Gallbladder Malignancy | completed | — | 180 | Osmania Medical CollegeOTHER_GOV | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05266300 | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. | completed | — | 722 | University of Southern DenmarkOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05047146 | The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt | completed | — | 530 | Sadat City UniversityOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT04780802 | Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma | completed | N/A | 10 | Chinese University of Hong KongOTHER | 1 | Oct 21, 2022 | clinicaltrials |
| NCT01176604 | Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma | completed | N/A | 299 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT02489422 | Programs To Support You During Chemotherapy(PRO-YOU) | completed | N/A | 44 | Wake Forest University Health SciencesOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT05068739 | Needle Knife Fistulotomy Versus Partial Ampullary Endoscopic Mucosal Resection for Difficult Biliary Cannulation | completed | N/A | 80 | Duzce UniversityOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT02128958 | Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 78 | Can-Fite BioPharmaINDUSTRY | 5 | Oct 4, 2022 | clinicaltrials |
| NCT04420026 | Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic Tumors(IAT) | completed | N/A | 44 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT00740753 | Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option(Y-90HDE) | completed | N/A | 339 | OHSU Knight Cancer InstituteOTHER | 0 | Sep 30, 2022 | clinicaltrials |
| NCT02072356 | Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery | completed | Early Phase 1 | 290 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT02702401 | Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) | completed | Phase 3 | 413 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 29, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Feb 16, 2023source: clinicaltrials